Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin.
D000469:Alkaline Phosphatase / Q000097:blood; D000636:Aminosalicylic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000097:blood; D007538:Isoniazid / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000201:enzymology*
D000636:Aminosalicylic Acids; D007521:Isocitrate Dehydrogenase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin